Poor medication adherence in clinical trials: consequences and solutions.
about
Adherence to fingolimod in multiple sclerosis: an investigator-initiated, prospective, observational, single-center cohort study.Considerations for Evaluating Treatment Effects From Randomized Clinical Trials.Nonsteroidal anti-inflammatory drug choice and adverse outcomes in clopidogrel users: A retrospective cohort study.The use of mechanistic evidence in drug approval
P2860
Poor medication adherence in clinical trials: consequences and solutions.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年学术文章
@wuu
2017年学术文章
@zh
2017年学术文章
@zh-cn
2017年学术文章
@zh-hans
2017年学术文章
@zh-my
2017年学术文章
@zh-sg
2017年學術文章
@yue
2017年學術文章
@zh-hant
name
Poor medication adherence in clinical trials: consequences and solutions.
@en
Poor medication adherence in clinical trials: consequences and solutions.
@nl
type
label
Poor medication adherence in clinical trials: consequences and solutions.
@en
Poor medication adherence in clinical trials: consequences and solutions.
@nl
prefLabel
Poor medication adherence in clinical trials: consequences and solutions.
@en
Poor medication adherence in clinical trials: consequences and solutions.
@nl
P2093
P50
P356
P1476
Poor medication adherence in clinical trials: consequences and solutions
@en
P2093
Alasdair Breckenridge
Carl C Peck
Dan Hartman
P2888
P304
P356
10.1038/NRD.2017.1
P577
2017-02-03T00:00:00Z